BLOCK JOHN R - 14 Mar 2022 Form 4 Insider Report for AEMETIS, INC (AMTX)

Role
Director
Signature
/s/Todd Waltz attorney-infact
Issuer symbol
AMTX
Transactions as of
14 Mar 2022
Net transactions value
-$663,178
Form type
4
Filing time
15 Mar 2022, 14:49:18 UTC
Previous filing
10 Jan 2022
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMTX Common Stock Sale $424,102 -35,000 -39% $12.12 54,627 14 Mar 2022 Direct F1
transaction AMTX Common Stock Options Exercise $60,200 -35,000 -28% $1.72 89,627 14 Mar 2022 Direct F2
transaction AMTX Common Stock Sale $15,752 -1,300 -2.4% $12.12 53,327 14 Mar 2022 Direct F3
transaction AMTX Common Stock Sale $228,591 -18,865 -35% $12.12 34,462 14 Mar 2022 Direct F4
transaction AMTX Common Stock Sale $125,667 +10,371 +76% $12.12 24,091 14 Mar 2022 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMTX Option (right to buy) Options Exercise $60,200 -35,000 -100% $1.72 0 14 Mar 2022 Common stock and Series B Preferred 35,000 $1.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017 and were sold on 3/14/2022 in the open market.
F2 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017.
F3 1,300 shares, which were acquired from the RSA grant on 1/7/2021, were sold on 3/14/2022 in the open market.
F4 18,865 shares, which were acquired from the RSA grant on 4/8/2021, were sold on 3/14/2022 in the open market.
F5 10,371 shares, which were acquired from the RSA grant on 1/6/2022, were sold on 3/14/2022 in the open market.
F6 As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 24,091 shares of the Issuers common stock.